Stephanie Wong's Net Worth
$103 Thousand
Who is Stephanie Wong?
Stephanie Wong does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Calithera Biosciences, Inc., AN2 Therapeutics, Inc., and SCICLONE PHARMACEUTICALS INC.
SEC CIK
Stephanie Wong's CIK is 0001555744
Past Insider Trading and Trends
2021 was Stephanie Wong's most active year for acquiring shares with 5 total transactions. Stephanie Wong's most active month to acquire stocks was the month of December. 2021 was Stephanie Wong's most active year for disposing of shares, totalling 2 transactions. Stephanie Wong's most active month to dispose stocks was the month of December. 2019 saw Stephanie Wong paying a total of $26,400.00 for 130,000 shares, this is the most they've acquired in one year. In 2021 Stephanie Wong cashed out on 61,531 shares for a total of $100,416.27, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Calithera Biosciences, Inc. (CALA) Snapshot price: $0.03
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.80% | -317.00 |
$0.45 | -$141.41 | 6.29K |
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
| -4.06% | -5.59K |
$0.49 | -$2,745.52 | 132.09K |
Jan 21
| |||
Form 4
| -11.61% | -18.08K |
$0.66 | -$11,938.05 | 137.67K |
Jan 4
| |||
Form 4
| +10.21% | 14.43K |
$0.87 | -$13,542.42 | 155.75K |
Nov 5 - Nov 8
| |||
Form 4
| +45.27% | 44.03K |
$1.89 | -$86,873.85 | 141.31K |
Oct 27 - Oct 28
| |||
Form 4
| +170.35% | 65K |
—
|
—
| 103.16K |
Jan 20
| |||
Form 4
| -14.25% | -5.00K |
$8.00 | -$40,000.00 | 30.08K |
Scheduled
|
Apr 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
| +45.97% | 10K |
$2.64 | $26,400.00 | 31.75K |
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 10
| |||
Form 4
| +200.00% | 10K |
$2.64 | $26,400.00 | 15K |
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 4
| -25.19% | -3.55K |
$18.41 | -$65,384.51 | 10.55K |
Scheduled
|
Jul 17
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AN2 Therapeutics, Inc. (ANTX) Snapshot price: $1.04
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SCICLONE PHARMACEUTICALS INC No price found
VP, Finance and Controller
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||